Stock market today: S&P 500 climbs as health care, tech gain; Nvidia earnings loom
Mesa Laboratories (NASDAQ:MLAB), a $515 million market cap company, saw its President and CEO Gary M. Owens sell 1,939 shares of company stock on June 16 at a price of $97.118, totaling approximately $188,311. The transaction comes as the stock has declined over 11% in the past week, according to InvestingPro data.
According to a Form 4 filing with the Securities and Exchange Commission, the transaction was to cover income tax obligations related to vested shares.
On June 15, Owens also exercised options to acquire 2,324 shares and 2,102 shares of Mesa Labs common stock at a price of $0. These shares represent common stock of Mesa Labs issued upon release of performance share units issued under the FY23 performance share unit program
Following these transactions, Owens directly owns 45,824 shares of Mesa Laboratories.
In other recent news, Mesa Laboratories, Inc. announced a change in its independent auditing firm following the merger of its previous auditor, Moss Adams LLP, with Baker Tilly US, LLP. Baker Tilly has been approved as the company’s new auditor, with no disagreements reported between Mesa Laboratories and Moss Adams during the fiscal year ending March 31, 2025. Additionally, Mesa Laboratories declared a quarterly dividend of $0.16 per share, payable on June 16, 2025, to shareholders on record as of May 30, 2025. The company has indicated expectations of revenue growth and operational results, although it cautions that actual outcomes may differ due to various risks and uncertainties. These forward-looking statements are part of Mesa’s ongoing financial activities and capital allocation strategy. Investors are advised to consider potential variations in results as detailed in the company’s filings with the Securities and Exchange Commission.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.